30572013|t|Acetylation as a major determinant to microtubule-dependent autophagy: Relevance to Alzheimer's and Parkinson disease pathology.
30572013|a|Protein post-translational modifications (PTMs) that potentiate protein aggregation have been implicated in several neurological disorders, including Alzheimer's (AD) and Parkinson's disease (PD). In fact, Tau and alpha-synuclein (ASYN) undergo several PTMs potentiating their aggregation and neurotoxicity. Recent data posits a role for acetylation in Tau and ASYN aggregation. Herein we aimed to clarify the role of Sirtuin-2 (SIRT2) and HDAC6 tubulin deacetylases as well as p300 acetyltransferase in AD and PD neurodegeneration. We used transmitochondrial cybrids that recapitulate pathogenic alterations observed in sporadic PD and AD patient brains and ASYN and Tau cellular models. We confirmed that Tau protein and ASYN are microtubules (MTs)-associated proteins (MAPs). Moreover, our results suggest that alpha-tubulin acetylation induced by SIRT2 inhibition is functionally associated with the improvement of MT dynamic determined by decreased Tau phosphorylation and by increased Tau/tubulin and ASYN/tubulin binding. Our data provide a strong evidence for a functional role of tubulin and MAPs acetylation on autophagic vesicular traffic and cargo clearance. Additionally, we showed that an accumulation of ASYN oligomers imbalance mitochondrial dynamics, which further compromise autophagy. We also demonstrated that an increase in Tau acetylation is associated with Tau phosphorylation. We found that p300, HDAC6 and SIRT2 influences Tau phosphorylation and autophagic flux in AD. In addition, we demonstrated that p300 and HDAC6 modulate Tau and Tubulin acetylation. Overall, our data disclose the role of Tau and ASYN modifications through acetylation in AD and PD pathology, respectively. Moreover, this study indicates that MTs can be a promising therapeutic target in the field of neurodegenerative disorders in which intracellular transport is altered.
30572013	84	117	Alzheimer's and Parkinson disease	Disease	MESH:D010300
30572013	245	267	neurological disorders	Disease	MESH:D009461
30572013	279	290	Alzheimer's	Disease	MESH:D000544
30572013	292	294	AD	Disease	MESH:D000544
30572013	300	319	Parkinson's disease	Disease	MESH:D010300
30572013	321	323	PD	Disease	MESH:D010300
30572013	335	338	Tau	Gene	4137
30572013	343	358	alpha-synuclein	Gene	6622
30572013	422	435	neurotoxicity	Disease	MESH:D020258
30572013	482	485	Tau	Gene	4137
30572013	547	556	Sirtuin-2	Gene	22933
30572013	558	563	SIRT2	Gene	22933
30572013	569	574	HDAC6	Gene	10013
30572013	633	635	AD	Disease	MESH:D000544
30572013	640	660	PD neurodegeneration	Disease	MESH:D010300
30572013	759	761	PD	Disease	MESH:D010300
30572013	766	768	AD	Disease	MESH:D000544
30572013	769	776	patient	Species	9606
30572013	788	792	ASYN	CellLine	CVCL:ZA47
30572013	797	800	Tau	Gene	4137
30572013	836	839	Tau	Gene	4137
30572013	943	956	alpha-tubulin	Gene	10376
30572013	980	985	SIRT2	Gene	22933
30572013	1083	1086	Tau	Gene	4137
30572013	1120	1123	Tau	Gene	4137
30572013	1474	1477	Tau	Gene	4137
30572013	1509	1512	Tau	Gene	4137
30572013	1544	1548	p300	Gene	2033
30572013	1550	1555	HDAC6	Gene	10013
30572013	1560	1565	SIRT2	Gene	22933
30572013	1577	1580	Tau	Gene	4137
30572013	1620	1622	AD	Disease	MESH:D000544
30572013	1658	1662	p300	Gene	2033
30572013	1667	1672	HDAC6	Gene	10013
30572013	1682	1685	Tau	Gene	4137
30572013	1750	1753	Tau	Gene	4137
30572013	1800	1802	AD	Disease	MESH:D000544
30572013	1807	1809	PD	Disease	MESH:D010300
30572013	1929	1956	neurodegenerative disorders	Disease	MESH:D019636
30572013	Association	MESH:D000544	22933
30572013	Association	MESH:D000544	10013
30572013	Association	10376	4137
30572013	Association	MESH:D020258	4137
30572013	Association	10013	4137
30572013	Association	22933	4137
30572013	Positive_Correlation	10376	22933
30572013	Association	MESH:D010300	4137
30572013	Association	MESH:D000544	4137
30572013	Association	2033	4137
30572013	Association	MESH:D020258	6622
30572013	Association	MESH:D000544	2033

